Page last updated: 2024-08-26

sr141716 and ER-Negative PR-Negative HER2-Negative Breast Cancer

sr141716 has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cao, S; Guo, H; Li, P; Li, Q; Li, S; Lin, Q; Sun, S; Wang, Y; Xia, Y; Yang, N; Zhang, W; Zheng, Z; Zhu, M	1

Other Studies

1 other study(ies) available for sr141716 and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism. Cell death & disease, 2022, 09-21, Volume: 13, Issue:9 Topics: Cell Death; Fatty Acids; Ferroptosis; Glutathione; Humans; Iron; Lipid Metabolism; Lipid Peroxides; Malondialdehyde; Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phospholipids; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Receptor, Cannabinoid, CB1; Rimonabant; Stearoyl-CoA Desaturase; Triple Negative Breast Neoplasms	2022

Article

Year

Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism.

Cell death & disease, 2022, 09-21, Volume: 13, Issue:9

Topics: Cell Death; Fatty Acids; Ferroptosis; Glutathione; Humans; Iron; Lipid Metabolism; Lipid Peroxides; Malondialdehyde; Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phospholipids; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Receptor, Cannabinoid, CB1; Rimonabant; Stearoyl-CoA Desaturase; Triple Negative Breast Neoplasms

2022